(Q34667211)

3 August 2017

title

Simple tandem repeat (TTTA)n polymorphism in CYP19 (aromatase) gene and breast cancer risk in Nigerian women (English)

1 reference

3 August 2017

1 reference

1 reference

8

Lewis H Kuller

1 reference

3 August 2017

Michael N Okobia

1

1 reference

3 August 2017

Clareann H Bunker

2

1 reference

3 August 2017

Joseph M Zmuda

3

1 reference

3 August 2017

Emmanuel R Ezeome

4

1 reference

3 August 2017

Stanley N C Anyanwu

5

1 reference

3 August 2017

Emmanuel E O Uche

6

1 reference

3 August 2017

Joseph Ojukwu

7

1 reference

3 August 2017

Robert E Ferrell

9

1 reference

3 August 2017

language of work or name

English

0 references

publication date

9 May 2006

1 reference

Journal of Carcinogenesis

3 August 2017

published in

1 reference

3 August 2017

volume

5

1 reference

3 August 2017

page(s)

12

1 reference

Aromatase and breast cancer susceptibility

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475832

Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475832

Aromatase inhibitors as potential cancer chemopreventives.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475832

Dual effects of weight and weight gain on breast cancer risk

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475832

Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475832

Chemoprevention of MNU-induced mammary tumorigenesis by hormone response modifiers: toremifene, RU 16117, tamoxifen, aminoglutethimide and progesterone.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475832

The human breast cancer cell line MDA-MB231 produces an aromatase stimulating activity.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475832

Prevention of spontaneous tumours in female rats by fadrozole hydrochloride, an aromatase inhibitor

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475832

Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475832

Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475832

Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475832

A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475832

Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475832

26 October 2018

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475832

Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475832

Chemopreventive effects of the aromatase inhibitors vorozole (R-83842) and 4-hydroxyandrostenedione in the methylnitrosourea (MNU)-induced mammary tumor model in Sprague-Dawley rats

26 October 2018

1 reference

12 December 2020

Regulation of aromatase expression in human tissues

1 reference

12 December 2020

Stromal spindle cells contain aromatase in human breast tumors

1 reference

12 December 2020

Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders

1 reference

12 December 2020

Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities

1 reference

12 December 2020

Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast

1 reference

12 December 2020

Arginine-cysteine polymorphism at codon 264 of the human CYP19 gene does not affect aromatase activity

1 reference

12 December 2020

A rare CYP19 (aromatase) variant may increase the risk of breast cancer

1 reference

12 December 2020

Genetic variants of CYP19 (aromatase) and breast cancer risk

1 reference

12 December 2020

A tetranucleotide repeat polymorphism inCYP19 and breast cancer risk

1 reference

12 December 2020

Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies

1 reference

12 December 2020

Aromatase activity and interleukin-6 production by normal and malignant breast tissues

1 reference

12 December 2020

Identifiers

DOI

10.1186/1477-3163-5-12

1 reference

3 August 2017

1 reference

3 August 2017

1 reference